Swiss Software Stock News

As the eurozone economy continues its modest recovery, with improved consumer and business confidence, European markets have shown resilience amidst global trade and geopolitical concerns. In this environment, dividend stocks can offer stability and income potential, making them an attractive option for investors looking to navigate the current market dynamics.

Sensirion Holding AG has launched the SCD53, a highly intrinsically stable CO₂ sensor designed to maintain long-term accuracy without manual recalibration or exposure to outdoor air, while offering integrated humidity, temperature and optional pressure compensation in a compact, easily integrated package. By eliminating reliance on automatic baseline calibration and enhancing robustness against dust, vibrations and mechanical stress, the SCD53 directly targets challenging applications such...

Novartis (SWX:NOVN) is back in focus after releasing its fourth quarter and full year 2025 results, pairing high single digit sales growth and a proposed higher dividend with softer guidance for 2026 core operating income. See our latest analysis for Novartis. The recent earnings release, softer 2026 core income guidance and the proposed CHF3.70 dividend appear to be contributing to building momentum. The 30 day share price return of 9.4% and 1 year total shareholder return of 24.7% extend...

As the European markets navigate a landscape marked by earnings optimism amidst trade and geopolitical concerns, the pan-European STOXX Europe 600 Index has shown resilience with modest gains. Against this backdrop, identifying stocks that are trading below their estimated worth can offer potential opportunities for investors seeking value in an environment where confidence is strengthening and economic recovery continues at a steady pace.

Galderma recently announced that the U.S. FDA has accepted its resubmitted Biologics License Application for RelabotulinumtoxinA, a neuromodulator for treating moderate-to-severe frown lines and crow’s feet in adults, following manufacturing process adjustments and backed by large phase III trial data. This milestone builds on Relfydess’s approvals in more than 20 markets and highlights Galderma’s efforts to broaden its injectable aesthetics franchise worldwide. We’ll now examine how the...

Why ARYZTA’s latest guidance is back in focus ARYZTA (SWX:ARYN) drew fresh attention after its 2025 sales and trading statement call on 22 January, alongside new earnings guidance for 2026 that points to revenue growth and improved performance for the year. For you as an investor, that combination of an updated outlook and a recent company communication creates a new reference point for reassessing ARYZTA’s current valuation, recent share price moves and the risks around its 2026 targets. See...

Idorsia has recently announced an exclusive license and supply agreement with EMS S.A. to register and commercialize its insomnia medicine QUVIVIQ (daridorexant) across Latin America, while also presenting long-term data on lucerastat suggesting disease-modifying potential in Fabry disease at the WORLDSymposium. Together, these developments highlight Idorsia’s push to expand QUVIVIQ into new geographies and progress lucerastat toward a defined regulatory path in a rare disease setting. We’ll...

In January 2026, BlackRock and Partners Group launched a first-of-its-kind multi-alternatives separately managed account on the Morgan Stanley wealth platform, giving advisors streamlined access to diversified private equity, private credit, and real assets through three outcome-aligned strategies. This structure is designed to remove common barriers to private market access by consolidating seven evergreen private market funds into a single, operationally simple solution for financial...

Cosmo Pharmaceuticals N.V. recently completed a private placement of 937,086 treasury shares, equivalent to about 5.3% of its outstanding shares, with Capital Group’s SMALLCAP World Fund, using only existing treasury stock and therefore avoiding dilution for current shareholders. The deal brings a globally recognized institutional investor into Cosmo’s shareholder base while providing additional financial flexibility to support its MedTech AI, dermatology, gastroenterology, and CDMO...

Sika recently expanded its global manufacturing network by opening five new plants in the United States, Argentina, Colombia, Bangladesh, and Tanzania to increase production capacity and reinforce its supply chain in key regions. This expansion underscores Sika’s emphasis on being closer to customers in growth markets, enhancing supply reliability and responsiveness across diverse construction material needs. We’ll now examine how this push to boost production capacity in key growth markets...

Adecco Group (SWX:ADEN) is back in focus after launching a global HR and talent consulting platform under its LHH brand. The move puts more weight on advisory services ahead of the upcoming earnings release. See our latest analysis for Adecco Group. The LHH launch comes as Adecco’s CHF23.20 share price sits slightly lower year to date, with a 4.3% 90 day share price return and an 11.5% 1 year total shareholder return, suggesting recent momentum has picked up after a weaker multi year...

Logitech G recently launched the G325 LIGHTSPEED Wireless Gaming Headset, a US$79.99 wireless model offering 24-bit audio, AI-powered noise reduction, LIGHTSPEED connectivity, and seamless switching across PC, consoles, and mobile via dongle and Bluetooth. By combining its proprietary LIGHTSPEED wireless technology with broad device compatibility at a lower price point, Logitech is pushing premium gaming features deeper into the mass-market segment. We’ll now examine how this value-focused...

ams-OSRAM’s ongoing turnaround has involved restructuring and moving away from low-margin LED activities toward automotive and industrial optical semiconductor applications, with management stressing operational improvements and debt reduction as priorities. An interesting angle is how investors and analysts are closely watching AI-driven demand for optical sensors as a potential earnings catalyst, while still highlighting considerable execution and leverage risks. Next, we’ll examine how...

As you might know, Roche Holding AG ( VTX:ROG ) recently reported its annual numbers. It was a pretty mixed result...

UBS Group (SWX:UBSG) has appointed Nicholas Hinnen as head of premium advisory specialists APAC Switzerland. The newly created role oversees a cross asset advisory team for ultra high and high net worth wealth management clients. The promotion reflects UBS's focus on its Swiss based affluent client segment and tailored advisory services. For you as an investor, this move highlights how UBS is leaning into its core wealth management franchise, where personalised advice and cross asset...

BD and Ypsomed Holding (SWX:YPSN) are expanding their collaboration around a new 5.5 mL BD Neopak XtraFlow Glass Prefillable Syringe, tailored for Ypsomed’s YpsoMate 5.5 large volume autoinjector platform. See our latest analysis for Ypsomed Holding. Despite the expanded BD partnership around large volume injectors, Ypsomed Holding’s 1 day share price return of 0.16% comes after a softer patch, with a 30 day share price return of 6.71% and a 1 year total shareholder return of 12.36%. This...

HIAG Immobilien Holding (SWX:HIAG) has drawn attention after issuing new guidance indicating that its 2025 consolidated net profit is expected to be 50% to 55% higher than the 2024 figure of CHF 75.2 million. See our latest analysis for HIAG Immobilien Holding. The updated profit outlook arrives after a solid run in HIAG Immobilien Holding's share price, with a 30 day share price return of 4.89%, a 90 day share price return of 13.09% and a 1 year total shareholder return of 45.44%, which...

Adecco Group’s LHH brand recently launched a global HR and talent consulting business, aiming to expand its higher-value advisory and support offerings. This move signals a push toward more consultative, margin-rich services that could reshape how Adecco balances traditional staffing with broader workforce solutions. Next, we’ll examine how this LHH consulting launch influences Adecco’s investment narrative, particularly its push into higher-margin HR services. Trump's oil boom is here -...

Why Lonza’s latest earnings matter for shareholders Lonza Group (SWX:LONN) just released full year 2025 results, issued 2026 sales growth guidance, and outlined a proposed 25% dividend increase, giving investors fresh information on profitability, cash returns, and future revenue expectations. See our latest analysis for Lonza Group. Despite the strong 2025 results and brighter 2026 sales guidance, Lonza Group’s recent momentum has been soft, with a 1 year total shareholder return decline of...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Mitsubishi Electric Corporation and Landis+Gyr Group (SWX:LAND) have signed a Memorandum of Understanding to work together on grid edge intelligence and energy transition solutions, initially targeting North American utilities. See our latest analysis for Landis+Gyr Group. The Mitsubishi Electric agreement lands after a recent Q3 sales or trading statement call and comes as the share price sits at CHF54.3, with a 7 day share price return of 6.68% but a 1 year total shareholder return of 8.23%...

In January 2026, BELIMO Holding AG reported its 2025 results, revealing accelerated sales growth of 23.3% in local currencies and CHF 1,121 million in sales. This sharp step-up in growth relative to the prior year highlights how BELIMO’s offering is gaining traction across its key end markets. We’ll now examine how this acceleration in sales growth shapes BELIMO’s investment narrative and what it could mean for investors. The end of cancer? These 29 emerging AI stocks are developing tech...

ABB Ltd has completed its 2025 share buyback, reported record fourth-quarter 2025 results with higher revenue and earnings, and announced a new US$2.00 billion share repurchase program running through January 27, 2027 for capital reduction and employee share plans. The company coupled the buyback with guidance for comparable revenue growth of 7%–10% for the first quarter and 6%–9% for full-year 2026, highlighting confidence backed by a record order backlog and expanding electrification and...

Shareholders of ABB Ltd ( VTX:ABBN ) will be pleased this week, given that the stock price is up 10% to CHF66.66...